Pharmacokinetic evaluation of different generic triclabendazole formulations in heifers

References

• Alvarez L, Imperiale F, Sanchez S, Murno G, Lanusse C. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Veterinary Parasitology 94, 75–89, 2000 doi: 10.1016/S0304-4017(00)00320-4
   PubMed Web of Science ®Google Scholar
• Alvarez-Sánchez MA, Mainar-Jaime RC, Pérez-García J, Rojo-Vázquez FA. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain. Veterinary Record 159, 424–5, 2006 doi: 10.1136/vr.159.13.424
   PubMed Web of Science ®Google Scholar
• *Anonymous. The use of animals in research, testing and teaching. Users guide to Part 6 of the New Zealand animal welfare act 1999. http://www.biosecurity.govt.nz/files/regs/animal-welfare/pubs/guide-animal-welfare-act-1999.pdf (accessed 22 February 2013). Ministry of Agriculture and Forestry, Wellington, New Zealand, 2000
   Google Scholar
• *Anonymous. Guideline for the conduct of bioequivalence studies for veterinary medicinal products. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004304.pdf (accessed 8 October 2013). The European Agency for the Evaluation of medicinal Products, Committee for Veterinary Medicinal Products, London, UK, 2001
   Google Scholar
• *Anonymous. Guidance for industry, Bioequivalence guidance. http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052363.pdf (accessed 20 September 2013). US Department of Health and Human Services, Food and Drug Administration, Center for Veterinary Medicine (CVM), Rockville, USA, 2006
   Google Scholar
• Boray J, Crowfoot P, Strong M, Allison J, Schellenbaum M, von Orelli M, Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Veterinary Record 113, 315–17, 1983 doi: 10.1136/vr.113.14.315
   PubMed Web of Science ®Google Scholar
• *Büscher G, Bowen F, Strong M, Crowfoot P. Efficacy of triclabendazole, its metabolites and other compounds in sheep. Proceedings of the 17th International Conference of the WAAVP. Pp 15–9, 1999
   Google Scholar
• Chambers E, Hoey E, Trudgett A, Fairweather I, Timson D. Binding of serum albumin to the anthelmintic drugs albendazole, triclabendazole and their sulphoxides. Veterinary Parasitology 171, 172–5, 2010 doi: 10.1016/j.vetpar.2010.02.043
   PubMed Web of Science ®Google Scholar
• Coles GC, Rhodes AC, Stafford KA. Activity of closantel against adult triclabendazole-resistant Fasciola hepatica. Veterinary Record 146, 504, 2000 doi: 10.1136/vr.146.17.504-a
   PubMed Web of Science ®Google Scholar
• Eslami A, Rassouli A, Meshki B, Shams G. A bioequivalence study of an albendazole oral suspension produced in Iran and a reference product in sheep. International Journal of Applied Research in Veterinary Medicine 4, 109–14, 2006
   Google Scholar
• Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. Journal of Helminthology 79, 227–34, 2005 doi: 10.1079/JOH2005298
   PubMed Web of Science ®Google Scholar
• Fairweather I. Triclabendazole progress report, 2005–2009: an advancement of learning? Journal of Helminthology 83, 139–50, 2009 doi: 10.1017/S0022149X09321173
   PubMed Web of Science ®Google Scholar
• Fairweather I. Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy? Veterinary Parasitology 180, 133–43, 2011 doi: 10.1016/j.vetpar.2011.05.034
   PubMed Web of Science ®Google Scholar
• *Gibaldi M, Perrier D. Pharmacokinetics. 2nd Edn. Pp 45–109. Marcel Dekker, Inc, New York, USA, 1982
   Google Scholar
• Halferty L, Brennan G, Trudgett A, Hoey L, Fairweather I. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica. Veterinary Parasitology 159, 126–38, 2009 doi: 10.1016/j.vetpar.2008.10.007
   PubMed Web of Science ®Google Scholar
• Hennessy D, Lacey E, Steel J, Prichard R. The kinetics of triclabendazole disposition in sheep. Journal of Veterinary Pharmacology and Therapeutics 10, 64–72, 1987 doi: 10.1111/j.1365-2885.1987.tb00078.x
   PubMed Web of Science ®Google Scholar
• Kinabo L, Bogan J. Pharmacokinetics and efficacy of triclabendazole in goats with induced fascioliasis. Journal of Veterinary Pharmacology and Therapeutics 11, 254–59, 1988 doi: 10.1111/j.1365-2885.1988.tb00150.x
   PubMed Web of Science ®Google Scholar
• Lanusse C, Prichard R. Effects of methimazole on the kinetics of netobimin metabolites in cattle. Xenobiotica 22, 115–23, 1992 doi: 10.3109/00498259209053108
   PubMed Web of Science ®Google Scholar
• Lanusse C, Prichard R. Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metabolism Reviews 25, 235–79, 1993 doi: 10.3109/03602539308993977
   PubMed Web of Science ®Google Scholar
• Lifschitz A, Virkel G, Ballent M, Sallovitz J, Lanusse C. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction. Veterinary Journal 182, 261–68, 2009 doi: 10.1016/j.tvjl.2008.06.001
   PubMed Web of Science ®Google Scholar
• Lo PKA, Fink DW, Williams JB, Blodinger J. Pharmacokinetic studies of ivermectin: effects of formulation. Veterinary Research Communications 9, 251–8, 1985 doi: 10.1007/BF02215150
   PubMed Web of Science ®Google Scholar
• *Martinez M, Berson M. Bioavailability/Bioequivalence. In: Hardee G, Baggot D (eds). Development and Formulation of Veterinary Dosage Forms. 2nd Edn. Pp 429–67. Marcel Dekker, New York, USA, 1998
   Google Scholar
• Moll L, Gaasenbeek CPH, Vellema P, Borgsteede FHM. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands. Veterinary Parasitology 91, 153–8, 2000 doi: 10.1016/S0304-4017(00)00267-3
   PubMed Web of Science ®Google Scholar
• Moreno L, Ceballos L, Fairweather I, Lanusse C, Alvarez L. Time-course and accumulation of triclabendazole/metabolites in bile, liver tissues and flukes collected from treated sheep. Experimental Parasitology 136, 14–9, 2014 doi: 10.1016/j.exppara.2013.10.014
   PubMed Web of Science ®Google Scholar
• Olaechea F, Lovera V, Larroza M, Raffo F, Cabrera R. Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina). Veterinary Parasitology 178, 364–6, 2011a doi: 10.1016/j.vetpar.2010.12.047
   PubMed Web of Science ®Google Scholar
• *Olaechea F, Larroza M, Solana H, Scarcella S, Carnevale S. An experimental study in sheep, to confirm triclabendazole resistance of Fasciola hepatica in Patagonia, Argentina. Proceedings of the 23rd. International Conference of the World Association for the Advancement of Veterinary Parasitology. P 85, 2011b
   Google Scholar
• Ortiz P, Scarcella S, Cerna C, Rosales C, Cabrera M, Guzmán M, Lamenza P, Solana H. Resistance of Fasciola hepatica against triclabendazole in cattle in Cajamarca (Peru): A clinical trial and an in vivo efficacy test in sheep. Veterinary Parasitology 195, 118–21, 2013 doi: 10.1016/j.vetpar.2013.01.001
   PubMed Web of Science ®Google Scholar
• Prichard R, Hennessy D, Steel J, Lacey E. Metabolite concentrations in plasma following treatment of cattle with five anthelmintics. Research in Veterinary Science 39, 113–78, 1985
   PubMed Web of Science ®Google Scholar
• Sánchez S, Alvarez L, Lanusse C. Fasting induced changes on the pharmacokinetic behaviour of albendazole and its metabolites in cattle. Journal of Veterinary Pharmacology and Therapeutics 20, 38–47, 1997 doi: 10.1046/j.1365-2885.1997.00810.x
   PubMed Web of Science ®Google Scholar
• Sanyal P. Kinetic disposition of triclabendazole in buffalo compared to cattle. Journal of Veterinary Pharmacology and Therapeutics 18, 370–4, 1995 doi: 10.1111/j.1365-2885.1995.tb00606.x
   PubMed Web of Science ®Google Scholar
• Suarez G, Alvarez L, Castells D, Correa O, Fagiolino P, Lanusse C. Comparative drug systemic exposure and clinical efficacy against resistant nematodes in lambs treated with different albendazole formulations. Journal of Veterinary Pharmacology and Therapeutics 34, 557–64, 2011 doi: 10.1111/j.1365-2885.2011.01274.x
   PubMed Web of Science ®Google Scholar
• Suarez G, Alvarez L, Castells D, Correa O, Fagiolino P, Lanusse C. Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs. BMC Veterinary Research 9, 27, 2013 doi: 10.1186/1746-6148-9-27
   PubMed Web of Science ®Google Scholar
• Van Wyk J, Malan F, Van Rensburg L, Oberem P, Allan M. Quality control in generic anthelmintics: Is it adequate?. Veterinary Parasitology 72, 157–65, 1997 doi: 10.1016/S0304-4017(97)00022-8
   PubMed Web of Science ®Google Scholar
• Virkel G, Lifschitz A, Sallovitz J, Pis A, Lanusse C. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics 29, 213–23, 2006 doi: 10.1111/j.1365-2885.2006.00735.x
   PubMed Web of Science ®Google Scholar